Worth £100 billion and home to 300,000 jobs, the UK life sciences sector is a key driver for economic growth and innovation. The government’s Modern Industrial Strategy and Life Sciences Sector Plan aim to propel it further.
Innovation incentives and reliefs are central to supporting that growth. As the UK’s leading R&D tax relief adviser and innovation incentives specialist, ForrestBrown has an established track-record of supporting businesses in the sector.
Our expert team unlock value through a holistic, forward-looking approach to incentives, leveraging them strategically throughout the innovation lifecycle. We will advise you on R&D tax relief, grants, Patent Box and capital allowances, giving you the confidence to shape what’s next.
Life sciences: a priority growth sector
Given the government’s ambition to position the UK as the leading life sciences economy in Europe by 2030, innovation incentives have a crucial role to play.
By unlocking the funding needed to support the next stage of development, incentives can drive long-term growth and business resilience in life sciences. In turn, powering progress and helping to build a thriving, future-ready economy.
Opportunities for innovation
From medicines and medical technologies to improving the speed and capacity to deliver commercial trials and research, opportunities to innovate in life sciences abound. Here are just four of the ways in which innovators are breaking new ground.
-
Existing therapeutics
Improving existing and developing new methodologies to target previously undruggable proteins and better existing therapeutic capabilities. -
Disease models
Creating new models to better understand diseases and evaluate the effectiveness and potential efficacy of emerging therapeutics. This has the potential to reduce the reliance on animal models and create a better understanding and evaluation of in vivo activity. -
Medical instrumentation and diagnostics
Development of new or improved surgical instruments or diagnostic capabilities, as well as improving the delivery of therapeutics into the body. -
Disease treatments
Using new and novel techniques to treat tumours and other diseases to extend the life expectancy of those with previously hard-to-treat medical conditions.
How ForrestBrown can help
As the UK’s leading R&D tax adviser and innovation incentives specialist, we bring a wealth of expertise to your project to help you unlock opportunity. Whether you’re a scaling SME or large multinational, ForrestBrown will help you make decisions with confidence and clarity. This enables you to secure financial benefit and strategic value.
Katy Long CTA CA
Director
Katy Long CTA CA
Director
- Qualified chartered tax adviser and chartered accountant.
- Experienced working with portfolio of large companies.
- Expert in R&D tax policy and legislation.
Expertise & specialisms
- R&D tax policy
- Overseas R&D rules
- Merged scheme
Beginning her career with a Big Four firm and gaining experience across a range of auditing and tax roles, Katy has specialised in R&D tax relief since joining ForrestBrown in 2019.
During a time of unprecedented change, Katy has led ForrestBrown’s approach to key policy developments including restrictions on overseas R&D activities and HMRC’s introduction of an additional information form. This has included liaising with HMRC, delivering internal training and providing insights to clients.
Clients working with Katy benefit from her commercial mindset and deep knowledge of R&D tax relief, including how it can work alongside other innovation incentives. She works with a range of established SMEs and large businesses in sectors including manufacturing, financial services and aerospace, where she is a trusted adviser on the RDEC incentive.
Katy co-authored the Tolley’s Tax Digest on R&D tax relief and has contributed articles to publications including Taxation and The CFO.
Kim Malik PhD
Senior Technical Manager
Kim Malik PhD
Senior Technical Manager
- Experienced scientist who helps communicate clients’ R&D projects to HMRC.
- Doctorate in Organic Chemistry and degree in Biological and Medicinal Chemistry.
- Gained R&D tax experience in the Big Four.
Expertise & specialisms
- Biological sciences
- Food & agricultural science
- Organic chemistry
Kim is an experienced scientist with a PhD in chemistry and degree in biochemistry. She has several years of Big Four tax credit experience and plays an invaluable role in communicating complex scientific R&D projects to HMRC.
After completing her PhD at the University of Exeter, Kim worked as a bench chemist and university tutor. She joined KPMG in 2007 and spent 13 years with the firm, working on RDEC claims for large companies.
At ForrestBrown, Kim brings her wealth of experience to our sector specialist team. She plays a key role in preparing claims by being a conduit between our clients’ technical teams and our tax specialists, enabling us to communicate our clients’ complex R&D projects effectively to HMRC.
She has signficant experience of working with large and complex clients, as well as SMEs. Her work is predominantly focused on clients that have a materials science, chemistry or food science element to their R&D.
Peter Beavis PhD CSci CChem
Senior Technical Manager
Peter Beavis PhD CSci CChem
Senior Technical Manager
- Highly experienced materials scientist.
- Background in food science, pharma and defence.
- Doctorate in organic chemistry.
Expertise & specialisms
- Materials engineering
- Pharma
- Defence
- Food & drink
Peter’s experience ranges from getting a PhD and MSci in Chemistry and improving confectionery shelf-life to the invention of a patented elastomeric material for improved radiation stability.
His career started with a role as a chocolate scientist at Mars. That was followed by a move to the defence sector, where he finished a nine-year stint as a Senior Materials Scientist at the Atomic Weapons Establishment.
During that period, he authored numerous scientific papers and spoke at international conferences on the synthesis and characterisation of novel polymers and materials. With ForrestBrown, Peter has also been published in The Manufacturer, The Medicine Maker, Interplas Insights, and the Confectionery Production publications.
That scientific and technical capability allows him to quickly understand, challenge and assess clients’ work against the R&D tax credit guidelines. And, it’s seeing the projects companies are able to fund due to the value of their claims – and the excitement they have – that’s driving him.
At ForrestBrown, Peter provides expert peer-to-peer communication for our clients on their technical projects, helping to translate their work into reports for HMRC. Examples of his work include reviewing a claim prepared by a Big Four accountancy firm – and significantly increasing the value of R&D tax relief to their business.
Pete works with our network of associations in the food and drink sector, using his background at Mars as a chocolate scientist to help businesses identify their hidden R&D in this industry. Supporting the activities of our partnerships team, Pete speaks at events, networks with businesses and hosts webinars with industry partners to raise awareness of the value of working with ForrestBrown’s expert multi-disciplinary team to access this valuable incentive.
With an infectious passion for all things science and materials, you can talk to Peter about pharma, food and drink, materials (adhesives, polymers and manufacturing) and engineering sectors.
Karim Budabuss CEng
Director – Grant Advisory
Karim Budabuss CEng
Director – Grant Advisory
- Grant advisory expert with Big Four experience.
- Significant experience supporting large businesses to access innovation incentives.
- Chartered engineer with the UK Engineering Council.
Expertise & specialisms
- Innovation funding
- Investment incentives and negotiated grants
- Decarbonisation projects
Karim works with large businesses, exploring all elements of the innovation toolkit, from R&D tax relief to grant funding. He takes a forward-looking approach, identifying opportunities which align with client projects and objectives.
Having previously led decarbonisation grant advisory for a Big Four firm in the UK, Karim joined ForrestBrown in 2023. His in-depth knowledge of grants provides further support for the innovative businesses we work with, enabling them to explore a wide range of funding opportunities.
Karim is a chartered engineer and gained more than five years’ experience as an engineering consultant and project manager for major infrastructure clients before specialising in innovation incentives. He has subsequently helped companies access millions of pounds from grant funding bodies such as Innovate UK, the Department of Energy Security and Net Zero, and Scottish Enterprise in sectors including aerospace, energy and manufacturing.
Through this combination of technical and finance expertise, Karim is well placed to advise businesses on their eligibility for innovation funding and the most appropriate projects for which to seek funding support, at the same time contributing to meeting some our biggest societal challenges.
At ForrestBrown, Karim has also supported multinational companies seeking to invest and create jobs in the UK, for example securing government support for the location of new manufacturing facilities.
Angela Banerjee ATT (Fellow)
Associate Director
Angela Banerjee ATT (Fellow)
Associate Director
- More than a decade of experience with Big Four and specialist R&D firms.
- Expert in UK Patent Box, working with businesses to commercialise IP.
- Dedicated support to Scottish businesses.
Expertise & specialisms
- UK taxation
- Patent Box relief
- Energy and net zero
Angela is an Associate Director with over 12 years’ experience advising on innovation incentives. She leads the delivery of Patent Box relief claims for clients, reducing Corporation Tax payments on profits related to intellectual property.
Based in ForrestBrown’s Scotland office, Angela provides dedicated local support to ensure that Scottish businesses are maximising their reward for investment in innovation, as well as working with businesses across the UK.
Following a range of advisory and consulting roles, including at KPMG and EY, Angela made the switch to ForrestBrown. She now focuses on helping innovative companies access innovation incentives with a focus on the Scottish market, particularly with businesses in the engineering and energy sectors who are striving to meet net zero demands and overcome supply chain issues.
Angela is passionate about the benefits of Patent Box, working with businesses to reward their investment in IP and amplify the benefits of their innovation.
Peter Reynolds ATT (Fellow) ICIOB
Partner – Capital Allowances
Peter Reynolds ATT (Fellow) ICIOB
Partner – Capital Allowances
- Leads ForrestBrown’s support for clients relating to capital allowances.
- Over 20 years’ experience working with businesses on asset taxation issues.
- Background in project management in the construction sector.
Expertise & specialisms
- Capital allowances and tax depreciation
- Fixed asset reporting for tax and accounting
- Cost segregation analysis for property investments
Peter specialises in capital allowances and leads ForrestBrown’s support for clients who buy, sell or incur expenditure refurbishing commercial property to optimise the tax reliefs available.
Previously a tax partner with a top 10 accountancy firm, Peter joined ForrestBrown in 2023. His in-depth knowledge of capital allowances provides further support for the innovative businesses we work with, helping to ensure they are fully rewarded for their investments.
Having started his career in the construction sector where he managed high profile projects throughout the UK and Europe, Peter combines a wealth of industry experience with technical tax knowledge to deliver pragmatic advice backed up by a deep understanding of how buildings are put together.
This mix of direct industry experience and technical tax expertise also enables Peter to structure fixed asset programmes that translate effectively for tax and accounting purposes. His approach delivers consistent, accurate information to financial teams, removing the risk of misinterpretation.
Peter draws on his experience working with FTSE100 and multinational companies across sectors including hospitality, retail, engineering and manufacturing to support ForrestBrown clients with tax reliefs relating to their investment in commercial property. Working alongside our grant advisory team, he also supports multinational businesses considering inward investment in the UK.
R&D tax relief
If your company is creating new technology or applying existing technologies in new and novel ways, you may be eligible to claim R&D tax relief. This flagship incentive is a key mechanism to help drive economic growth and delivers spillover benefits to the UK economy.
ForrestBrown’s award-winning team can provide end-to-end management of your R&D claim, including eligibility assessment, submission and liaison with HMRC. We can also support you with establishing and reviewing your in-house R&D claim capabilities, giving you greater confidence in your internal processes.
Our tax experts work seamlessly with our industry-experienced sector specialists to review the scope of your R&D. This ensures that your claim is robust and captures its full value. They will work with your competent professional to review your projects, before translating your R&D into accessible language – acting as the bridge between you and HMRC.
At ForrestBrown, technical excellence is complemented by secure systems and technology to process your claim. This gives you the peace of mind that your claims will be prepared rigorously, efficiently and securely.
Grants
The life sciences sector is supported by a wealth of grant funding opportunity. This includes the headline Life Sciences Innovative Manufacturing Fund, which makes £520 million available for life sciences manufacturing over five years (2025-2030). LSIMF is complemented by the Life Sciences Transformational R&D Investment Fund (TRIF) Pilot, which focuses on early-stage innovation and transformative R&D.
ForrestBrown’s experienced grant advisory team, led by Karim Budabuss, is ideally placed to advise your business on applications to either fund. We can also support you with applications to the Biomedical Catalyst and Growth Catalyst, both of which provide funding for life sciences businesses.
Whichever stage of the grant funding journey you’re at, we can help. From horizon scanning and feasibility assessment, to application review and project management, we have the skills and expertise to support you.
Patent Box
New medical products or processes are often patented, allowing the inventor a period of market exclusivity. Where patents do exist, it’s important for businesses to consider claiming Patent Box relief – a Corporation Tax (CT) relief on patented products or processes, that reduces the CT rate on qualifying IP income to 10%.
It is a significant relief and one that can be claimed each year on renewal of the patent. Our experienced Patent Box team, led by Angela Banerjee ATT, can support you with your claim and help to dispel the many myths that exist in relation to Patent Box and life sciences. This ensures an efficient claim process for your business.
Location strategy
With 41% of the life science sector’s turnover generated outside of London, the South East, and the East of England, a range of location options are available to businesses. This includes Liverpool City Region and West Yorkshire – the government’s dedicated life sciences investment zones.
Our location strategy experts can help you to evaluate which geographic region will work for your business, based on a range of factors including the availability of talent, connectivity and location incentives. We handle the entire process, from defining the project and evaluating locations based on agreed success criteria, to visiting shortlisted locations and performing due diligence on finalist locations prior to recommendations.
Capital allowances
Scaling up life sciences manufacturing or investing in R&D will likely mean investment in facilities. If your business falls into that category, why not explore your eligibility for capital allowances relief?
It can bring significant cash flow benefits for any eligible capital expenditure, such as plant and equipment, providing valuable resources to reinvest in further growth.
Our capital allowances team, led by Peter Reynolds, has considerable experience working on asset taxation issues, as well as in the construction industry. That perfect combination of industry experience and technical authority enables ForrestBrown to deliver practical, actionable advice to support your business.
Examples of life sciences firms advised by ForrestBrown
Stablepharma
Stablepharma, a trailblazer in pharmaceutical technology focused on developing fridge-free vaccines through its StablevaX™ platform, relies heavily on continuous R&D investment to push scientific boundaries and save lives. ForrestBrown’s sector-specialist expertise and proactive support have helped Stablepharma unlock R&D tax relief quickly and efficiently, allowing the team to concentrate on world-leading innovation without unnecessary administrative burden. This partnership has been pivotal in fuelling ongoing research and attracting further investment, enabling Stablepharma to advance its life-saving work and grow with confidence.
Exico
ForrestBrown helped IXICO, a global leader in neuroimaging and biomarker analytics, successfully secure grant funding to advance a key project by preparing and submitting a timely application on IXICO’s behalf. With a tight deadline and busy internal schedules, ForrestBrown stepped in to prioritise and compile the necessary information, taking ownership of the application process so the IXICO team could focus on review and oversight. The outcome was a successful grant award that will support progress on an important initiative designed to aid early dementia diagnosis, demonstrating the value of expert grant support and collaboration.
Grena
Grena Ltd, a global maker of innovative disposable medical devices, was aware of the UK Patent Box regime but wasn’t claiming relief on its patented products. Because ForrestBrown already understood Grena’s business through ongoing R&D support, the team took a holistic view of innovation incentives, identified the untapped value of Patent Box relief, and led the claim process. By combining expertise across incentives and working closely with the client, ForrestBrown made claiming Patent Box straightforward and efficient, freeing up Grena to focus on developing its products while benefiting from valuable tax savings.
Ready to discuss your funding strategy?
With over a decade’s experience partnering with forward-thinking businesses to unlock innovation incentives and reliefs, ForrestBrown has the skills needed to support your future funding strategy.
By providing market-leading, holistic advice, we ensure that your business can claim with confidence, knowing that all value has been captured and risk managed.
If you would like to discuss how to maximise your innovation funding strategy in the life sciences, get in touch.
- Telephone
- 0117 926 9022
- hello@forrestbrown.co.uk